Owen Brimhall

ProLung, Inc. is a medical technology company, which specializes in predictive analytics technology, early stage lung cancer risk testing. It develops, tests and commercializes solutions which are designed to accelerate the time to diagnosis and expand the therapeutic window for lung cancer patients. Its product under the name of ProLung Test was developed to assess the risk of malignancy in lung nodules found in the chest by a Computed Tomography scan. The company was founded by Steven C. Eror on November 19, 2004 and is headquartered in Salt Lake City, UT.